The University of Iowa Campus

Resources For...

Faculty & Staff                              Students                                  Community


The Human Subjects Office (HSO) was established by the Vice President for Research to provide administrative support for the University of Iowa Institutional Review Boards. An Institutional Review Board is a group of individuals charged with reviewing proposed research involving human subjects to ensure the protection of those subjects and compliance with federal human subjects regulations. The University of Iowa has three such review boards, each consisting of faculty, staff, and representatives from the Iowa City community.


The mission of the University of Iowa Institutional Review Boards is to assure that the rights and welfare of human subjects are adequately protected in research.

Upcoming Events

Wed, Sep 03, 2014 - 2:00pm to 4:00pm

Office Hours Wednesday Fall 2014 - Location: 101 Hardin Library

Thu, Sep 04, 2014 - 10:00am to 12:00pm

Office Hours - Location: 101 Hardin Library

Fri, Sep 05, 2014 - 9:00am to 11:30am

How to Complete a New Project Application - Location: Hardin Library Information Commons EAST

Upcoming Meetings

Thu, Sep 04, 2014 - 2:00pm to 5:00pm

IRB-01 Full Board Meeting - Location: 101 HLHS

Thu, Sep 11, 2014 - 2:00pm to 5:00pm

IRB-01 Full Board Meeting - Location: 101 HLHS


HSO Career Opportunity

Requisition # 65005: Education & Compliance Specialist, Human Subjects Office 

NIH Policy on Genomic Data Sharing

The National Institutes of Health (NIH) has recently issued a final NIH Genomic Data Sharing (GDS) policy. This policy is in place to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants.  The policy will apply to all NIH-funded, large-scale human and non-human projects that generate genomic data.

FDA Final Guidance for Investigational Device Exemptions (IDE) Clinical Investigations

The Food and Drug Administration (FDA) has recently issued a final guidance document on

IRB Updates - Changes to P&T and P&T IDS approval process

Changes to the Pharmacy & Therapeutics (P&T) Review and Approval of Human Subjects Research Effective immediately, any IRB-01 or IRB-03 researchers conducting human subjects research requiring P&T approval needs to be aware that the Pharmacy & Therapeutics Committee and the Pharmacy & Therapeutics Investigational Drug Service (IDS) reviews have now been split.  P&T and P&T IDS will be recognized as two separate committee reviews in the HawkIRB application system.  

Live webcast of the Secretary’s Advisory Committee for Human Research Protections (SACHRP)

The July 21-22 2014 meeting of the Secretary’s Advisory Committee for Human Research Protections (SACHRP) will be webcast live at For the SACHRP agenda, go to:,2014sachrpmeeting.html.